See how strategic acquisitions and the launch of several first-of-their-kind products spurred significant growth and helped us make a meaningful impact in more patients’ lives

Meaningful Innovations

WATCHMAN™ Left Atrial Appendage Closure Device WATCHMAN™ is the first proven alternative to long-term warfarin therapy for stroke risk reduction in patients with non-valvular atrial fibrillation.
SYNERGY has the only bioabsorbable polymer to be absorbed shortly after drug elution ends at three months to help free patients from long-term polymer exposure.
The EMBLEM™ S-ICD System is the world's first and only commercially available subcutaneous implantable defibrillator
LithoVue overcomes common challenges of reusable scopes during minimally invasive endoscopic procedures.
This single-operator system for direct visualization cholangioscopy and pancreatoscopy offers increased productivity, easier setup and enhanced image quality.
Our advanced transcatheter aortic valve replacement (TAVR) technology enables precise positioning and placement during implantation.
ELUVIA uses the anti-restenotic drug paclitaxel in conjunction with a polymer to provide an advanced treatment option for patients with peripheral artery disease.
Alair is the first and, currently, only non-drug therapy for severe asthma with clinically proven benefits that last at least five years.
The Genesys HTA™ System treats excessive uterine bleeding and offers an alternative to a hysterectomy for some premenopausal women.


Growth and Acquisitions

The AMS acquisition makes Boston Scientific the clear category leader and provides customers with the most comprehensive urology portfolio in the industry. | This successful acquisition helped the peripheral interventions business grow share in the atherectomy and thrombectomy categories.
This acquisition enhanced our overall electrophysiology business by differentiating and expanding our commercial presence and product portfolio. | Established nine global IAS locations that offer healthcare professionals hands-on, multidisciplinary training programs for our products and procedures.
The ADVANTICS™ Healthcare Solutions launch allows us to deliver tailored solutions that help customers sustain change and drive growth. | Significant investments in people, infrastructure, distribution and clinical science in China and India are helping us drive growth in emerging markets.


One of the most inspiring leaders in the industry, Mahoney is known for building market-leading global businesses in the healthcare field